Innoviva (INVA) News Today

Victory Capital Management Inc. grew its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 63.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 135,755 shares of the biotechnology company's stock after purchasing an add

Denali Advisors LLC boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 34.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 439,786 shares of the biotechnology company's stock after acquiring an additiona

Bokf Na lifted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 180.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 46,377 shares of the biotechnology company's stock after purchasing an additional 2

Los Angeles Capital Management LLC trimmed its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 83.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,664 shares of the biotechnology compa

Innoviva (NASDAQ:INVA) Sets New 12-Month High at $19.87

Innoviva (NASDAQ:INVA) Reaches New 1-Year High at $19.78

Hussman Strategic Advisors Inc. reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 50.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 84,000 shares of the biotechnology company's stock after selling 84,00

Innoviva (NASDAQ:INVA) Reaches New 12-Month High at $19.45

SG Americas Securities LLC raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 797.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,500 shares of the biotechnology company's stock afte

Harbor Capital Advisors Inc. raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 394.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,895 shares of the biotechnology company's

Comerica Bank trimmed its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 29.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 184,142 shares of the biotechnology company's stock after selling 77,407

StockNews.com lowered shares of Innoviva from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.

Vanguard Group Inc. decreased its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 6.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,286,013 shares of the biotechnology company's stock after selling 426,430 shares during the quart

Innoviva, Inc. (NASDAQ:INVA - Free Report) - Analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for shares of Innoviva in a note issued to investors on Thursday, August 1st. Cantor Fitzgerald analyst L. Chen now anticipates that the biotechnology company will post earnings per

Boston Partners boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 90.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 391,456 shares of the biotechnology company's stock after buying an additio

Cantor Fitzgerald reiterated an "overweight" rating on shares of Innoviva in a report on Tuesday.

State Board of Administration of Florida Retirement System lessened its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 81.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,622 shares of the bio

Innoviva (NASDAQ:INVA) Sets New 52-Week High at $18.70

O Shaughnessy Asset Management LLC lifted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 108.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 73,066 shares of the biotechnology company's stock after purchasing an ad

StockNews.com cut shares of Innoviva from a "strong-buy" rating to a "buy" rating in a report on Wednesday.

Innoviva (NASDAQ:INVA) Reaches New 1-Year High at $17.62

Westfield Capital Management Co. LP reduced its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 19.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,111,663 shares of the biotechnology company's stock after se

SageView Advisory Group LLC acquired a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 102,012 shares of the biotechnology company's sto

Innoviva, Inc. (NASDAQ:INVA - Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 11,270,000 shares, a decrease of 8.2% from the June 15th total of 12,280,000 shares. Approximately 18.3% of the shares of the company are short sold. Based on an average daily trading volume, of 534,400 shares, the days-to-cover ratio is presently 21.1 days.

Innoviva (NASDAQ:INVA) Hits New 12-Month High at $17.24

StockNews.com upgraded shares of Innoviva from a "buy" rating to a "strong-buy" rating in a research report on Monday.

LSV Asset Management cut its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 61.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 98,600 shares of the biotechnology company'

Innoviva (NASDAQ:INVA) Sets New 12-Month High at $16.87

Wellington Management Group LLP acquired a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 120,926 shares of the biotechnology company's stoc

Innoviva (NASDAQ:INVA) Sees Unusually-High Trading Volume

CWA Asset Management Group LLC bought a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 253,759 shares of the biotechnology company's stock, valued at approximately $4,070,000. CWA Asse

Charles Schwab Investment Management Inc. raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 17.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 933,259 shares of the biotechnology co

Dimensional Fund Advisors LP increased its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,516,999 shares of the biotechnology company's

Westfield Capital Management Co. LP raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 27.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,614,127 shares of the biotechnology company's stock after purc

Hillsdale Investment Management Inc. purchased a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 290,700 shares of the biotechnology company's

Boston Partners trimmed its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 47.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 205,672 shares of the biotechnology company's stock after selling 1

Jump Financial LLC raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 281.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 91,995 shares of the biotechnology company's stock after purchasing an additio